Actos Cancer Lawsuit
Actos Bladder Cancer Lawsuit
June 2011, the FDA issued an Actos warning notice to inform the public of bladder cancer side effects in diabetes patients caused by Actos. The French and German government has suspended all sales of Actos due to the data showing the dangers of Actos and Bladder cancer. In light of these events, Actos Cancer Lawsuits are being reviewed nation wide for Actos users who have been diagnosed with bladder cancer.
Actos is manufactured by Takeda Pharmaceuticals and has been used by more than to more two million type-2 diabetes patients in 2010. Actos became a popular alternative to Avandia, which had been associated with an increased risk of strokes andf heat attacks in patients.
Actos Cancer Lawsuit Filed
An Actos Cancer Lawsuit was filed against Takeda Pharmaceuticals, manufacturer Actos® (pioglitazone), was recently filed n the United States District Court for the Central District of California. This Actos Lawsuit, one of the first filed against manufacturer of Actos by a pateint who developed an aggressive form of bladder cancer after taking Actos® for over two years. the Acto Lawsuit Complaint, alleges that Takeda failed to warn of the risks of bladder cancer and that if the pateient had been made aware of the dangers connected with the drug, an alternative course of treatment would have been sought. The Patient in this Actos Cancer Lawsuit is seeking monetary damages from Takeda.
You may be entitled to Compensation
If you or a loved one has been injured as a result of taking Actos or want to learn more about the Actos Cancer Lawsuit , contact us now to speak with our qualified Actos Cancer Lawyer about possible compensation and information about Actos bladder cancer. Call us now at 877-222-7069 or use the contact form for a free case review.
Actos Cancer attorneys at are currently reviewing the potential for Actos cancer lawsuits. If it is proven that these drug manufacturers have placed profits ahead of patient safety by failing to adequately warn users concerning the potential risk of bladder cancer, patients diagnosed with bladder cancer may be compensation through an Actos lawsuit.
Our Newsletter
Latest FDA Alerts
-
FDA Issues Topamax Warning
A Topamax Warning has been issued by the FDA concerning new data that links Topamax ,…
-
Hip Replacement Recall Announced
DePuy Orthopaedics, a unit of Johnson & Johnson, announced the recall of two of it hip replacement…
-
The U.S. Food and Drug Administration (FDA) is recommending against continued prescribing and use of Meridia (sibutramine) because this drug…
-
FDA issues warnings to marketers of unapproved ‘Chelation’ productsThe U.S. Food and Drug Administration today warned eight companies…
Hyland’s Teething Tablets may pose a risk to children
The U.S. Food and Drug Administration today is warning consumers that…

